{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:44:58Z","timestamp":1790390698528,"version":"4.1.0"},"reference-count":36,"publisher":"Japanese Society of Toxicology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2131\/jts.42.183","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T22:24:57Z","timestamp":1489703097000},"page":"183-192","source":"Crossref","is-referenced-by-count":22,"title":["Characterization of human iPS cell-derived cardiomyocyte sheets as a model to detect drug-induced conduction disturbance"],"prefix":"10.2131","volume":"42","author":[{"given":"Hiroko","family":"Izumi-Nakaseko","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Kanda","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, National Institute of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Sekino","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, National Institute of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abete, P., Ferrara, N., Rengo, F. and Vassalle, M. (1991): Mechanisms of lidocaine actions on normal and abnormal rhythms in canine cardiac tissues <i>in vivo<\/i> and <i>in vitro<\/i>. Clin. Exp. Pharmacol. Physiol., <b>18<\/b>, 179-191.","DOI":"10.1111\/j.1440-1681.1991.tb01429.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Asakura, K., Hayashi, S., Ojima, A., Taniguchi, T., Miyamoto, N., Nakamori, C., Nagasawa, C., Kitamura, T., Osada, T., Honda, Y., Kasai, C., Ando, H., Kanda, Y., Sekino, Y. and Sawada, K. (2015): Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes. J. Pharmacol. Toxicol. Methods., <b>75<\/b>, 17-26.","DOI":"10.1016\/j.vascn.2015.04.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Doss, M.X., Di Diego, J.M., Goodrow, R.J., Wu, Y., Cordeiro, J.M., Nesterenko, V.V., Barajas-Mart\u00ednez, H., Hu, D., Urrutia, J., Desai, M., Treat, J.A., Sachinidis, A. and Antzelevitch, C. (2012): Maximum diastolic potential of human induced pluripotent stem cell-derived cardiomyocytes depends critically on I<sub>Kr<\/sub>. PLoS One, <b>7<\/b>, e40288.","DOI":"10.1371\/journal.pone.0040288"},{"key":"4","unstructured":"Fozzard, H.A. and Arnsdorf, M.F. (1992): Cardiac electrophysiology, In The Heart and Cardiovascular System: Scientific Foundations. 2nd ed. (Fozzard, H.A., Haber, E., Katz, A.M., Morgan, H.A. and Jennings, R.B. eds), pp.99-110, Raven Press, New York."},{"key":"5","doi-asserted-by":"crossref","unstructured":"Gibson, J.K., Yue, Y., Bronson, J., Palmer, C. and Numann, R. (2014): Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents. J. Pharmacol. Toxicol. Methods, <b>70<\/b>, 255-267.","DOI":"10.1016\/j.vascn.2014.09.005"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Harper, R.W., Whitford, E., Middlebrook, K., Federman, J., Anderson, S. and Pitt, A. (1982): Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome. Am. J. Cardiol., <b>50<\/b>, 1323-1330.","DOI":"10.1016\/0002-9149(82)90470-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Harris, K., Aylott, M., Cui, Y., Louttit, J.B., McMahon, N.C. and Sridhar, A. (2013): Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays. Toxicol. Sci., <b>134<\/b>, 412-426.","DOI":"10.1093\/toxsci\/kft113"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Johannesen, L., Vicente, J., Mason, J.W., Sanabria, C., Waite-Labott, K., Hong, M., Guo, P., Lin, J., S\u00f8rensen, J.S., Galeotti, L., Florian, J., Ugander, M., Stockbridge, N. and Strauss, D.G. (2014): Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil. Clin. Pharmacol. Ther., <b>96<\/b>, 549-558.","DOI":"10.1038\/clpt.2014.155"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Johannesen, L., Vicente, J., Mason, J.W., Erato, C., Sanabria, C., Waite-Labott, K., Hong, M, Lin, J., Guo, P., Mutlib, A., Wang, J., Crumb, W.J., Blinova, K., Chan, D., Stohlman, J., Florian, J., Ugander, M., Stockbridge, N. and Strauss, D.G. (2016): Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial. Clin. Pharmacol. Ther., <b>99<\/b>, 214-223.","DOI":"10.1002\/cpt.205"},{"key":"10","unstructured":"Josephson, M.E. (1993): Electrophysiological investigation: General concepts, In Clinical Cardiac Electrophysiology: Techniques and Interpretations. 2nd ed. (Josephson, M.E., ed.), pp.22-70, Lea &amp; Febiger, Philadelphia."},{"key":"11","doi-asserted-by":"crossref","unstructured":"Kadota, S., Minami, I., Morone, N., Heuser, J.E., Agladze, K. and Nakatsuji, N. (2013): Development of a reentrant arrhythmia model in human pluripotent stem cell-derived cardiac cell sheets. Eur. Heart J., <b>34<\/b>, 1147-1156.","DOI":"10.1093\/eurheartj\/ehs418"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Kihara, Y., Inoko, M., Hatakeyama, N., Momose, Y. and Sasayama, S. (1996): Mechanisms of negative inotropic effects of class Ic antiarrhythmic agents: comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in dog ventricular myocardium. J. Cardiovasc. Pharmacol., <b>27<\/b>, 42-51.","DOI":"10.1097\/00005344-199601000-00008"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Lee, P., Klos, M., Bollensdorff, C., Hou, L., Ewart, P., Kamp, T.J., Zhang, J., Bizy, A., Guerrero-Serna, G., Kohl, P., Jalife, J. and Herron, T.J. (2012): Simultaneous voltage and calcium mapping of genetically purified human induced pluripotent stem cell-derived cardiac myocyte monolayers. Circ. Res., <b>110<\/b>, 1556-1563.","DOI":"10.1161\/CIRCRESAHA.111.262535"},{"key":"14","unstructured":"Levy, M.N. and Pappano, A.J. (2007), Automaticity: Natural excitation of the heart, In Cardiovascular Physiology. 9th ed. (Levy, M.N. and Pappano, A.J., eds.), pp.33-54, Mosby, Inc, Philadelphia."},{"key":"15","doi-asserted-by":"crossref","unstructured":"Ma, J., Guo, L., Fiene, S.J., Anson, B.D., Thomson, J.A., Kamp, T.J., Kolaja, K.L., Swanson, B.J. and January, C.T. (2011): High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am. J. Physiol. Heart Circ. Physiol., <b>301<\/b>, H2006-H2017.","DOI":"10.1152\/ajpheart.00694.2011"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Mehta, A., Chung, Y., Sequiera, G.L., Wong, P., Liew, R. and Shim, W. (2013): Pharmacoelectrophysiology of viral-free induced pluripotent stem cell-derived human cardiomyocytes. Toxicol. Sci., <b>131<\/b>, 458-469.","DOI":"10.1093\/toxsci\/kfs309"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Meijer van Putten, R.M., Mengarelli, I., Guan, K., Zegers, J.G., van Ginneken, A.C., Verkerk, A.O. and Wilders, R. (2015): Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual I<sub>K1<\/sub>. Front. Physiol.,<b> 6<\/b>, 7.","DOI":"10.3389\/fphys.2015.00007"},{"key":"18","unstructured":"Miller, J.M. and Zipes, D.P. (2008): Diagnosis of cardiac arrhythmias. In Braunwald\u2019s Heart Disease. 8th ed. (Libby, P., Bonow, R.O., Mmann, D.L., Zipes, D.P. and Braunwald, E., eds.), pp.763-778, Saunders, Philadelphia."},{"key":"19","doi-asserted-by":"crossref","unstructured":"Nakamura, Y., Matsuo, J., Miyamoto, N., Ojima, A., Ando, K., Kanda, Y., Sawada, K., Sugiyama, A. and Sekino, Y. (2014): Assessment of testing methods for drug-induced repolarization delay and arrhythmias in an iPS cell-derived cardiomyocyte sheet: multi-site validation study. J. Pharmacol. Sci., <b>124<\/b>, 494-501.","DOI":"10.1254\/jphs.13248FP"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Navarrete, E.G., Liang, P., Lan, F., Sanchez-Freire, V., Simmons, C., Gong, T., Sharma, A., Burridge, P.W., Patlolla, B., Lee, A.S., Wu, H., Beygui, R.E., Wu, S.M., Robbins, R.C., Bers, D.M. and Wu, J.C. (2013): Screening drug-induced arrhythmia using human induced pluripotent stem cell\u2013derived cardiomyocytes and low-impedance microelectrode arrays. Circulation, <b>128<\/b>, S3-S13.","DOI":"10.1161\/CIRCULATIONAHA.112.000570"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Nawrath, H. and Wegener, J.W. (1997): Kinetics and state-dependent effects of verapamil on cardiac L-type calcium channels. Naunyn. Schmiedebergs. Arch. Pharmacol., <b>355<\/b>, 79-86.","DOI":"10.1007\/PL00004921"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Nozaki, Y., Honda, Y., Tsujimoto, S., Watanabe, H., Kunimatsu, T. and Funabashi, H. (2014): Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation. Toxicol. Appl. Pharmacol., <b>278<\/b>, 72-77.","DOI":"10.1016\/j.taap.2014.04.007"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Nunes, S.S., Miklas, J.W., Liu, J., Aschar-Sobbi, R., Xiao, Y., Zhang, B., Jiang, J., Mass\u00e9, S., Gagliardi, M., Hsieh, A., Thavandiran, N., Laflamme, M.A., Nanthakumar, K., Gross, G.J., Backx, P.H., Keller, G. and Radisic, M. (2013): Biowire: a new platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods., <b>10<\/b>, 781-787.","DOI":"10.1038\/nmeth.2524"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Okada, J., Yoshinaga, T., Kurokawa, J., Washio, T., Furukawa, T., Sawada, K., Sugiura, S. and Hisada, T. (2015): Screening system for drug-induced arrhythmogenic risk combining a patch clamp and heart simulator. Sci. Adv., <b>1<\/b>, e1400142.","DOI":"10.1126\/sciadv.1400142"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Peng, S., Lacerda, A.E., Kirsch, G.E., Brown, A.M. and Bruening-Wright, A. (2010): The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes. J. Pharmacol. Toxicol. Methods., <b>61<\/b>, 277-286.","DOI":"10.1016\/j.vascn.2010.01.014"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Ramos, E. and O\u2019leary, M.E. (2004): State-dependent trapping of flecainide in the cardiac sodium channel. J. Physiol., <b>560<\/b>, 37-49.","DOI":"10.1113\/jphysiol.2004.065003"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Rao, C., Prodromakis, T., Kolker, L., Chaudhry, U.A., Trantidou, T., Sridhar, A., Weekes, C., Camelliti, P., Harding, S.E., Darzi, A., Yacoub, M.H., Athanasiou, T. and Terracciano, C.M. (2013): The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. Biomaterials, <b>34<\/b>, 2399-2411.","DOI":"10.1016\/j.biomaterials.2012.11.055"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Sugiyama, A., Motomura, S. and Hashimoto, K. (1994): Utilization of an isolated, blood-perfused canine papillary muscle preparation as a model to assess efficacy and adversity of class I antiarrhythmic drugs. Jpn. J. Pharmacol., <b>66<\/b>, 303-316.","DOI":"10.1254\/jjp.66.303"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. (1991): The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation, <b>84<\/b>, 1831-1851.","DOI":"10.1161\/01.CIR.84.4.1831"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Trautwein, W., Kassebaum, D.G., Nelson, R.M. and Hecht, H.H. (1962): Electrophysiological study of human heart muscle. Circ. Res., <b>10<\/b>, 306-312.","DOI":"10.1161\/01.RES.10.3.306"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Uesugi, M., Ojima, A., Taniguchi, T., Miyamoto, N. and Sawada, K. (2014): Low-density plating is sufficient to induce cardiac hypertrophy and electrical remodeling in highly purified human iPS cell-derived cardiomyocytes. J. Pharmacol. Toxicol. Methods., <b>69<\/b>, 177-188.","DOI":"10.1016\/j.vascn.2013.11.002"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Vaughan Williams, E.M. (1992): The relevance of cellular to clinical electrophysiology in classifying antiarrhythmic actions. J. Cardiovasc. Pharmacol., <b>20<\/b> Suppl 2, S1-S7. Review.","DOI":"10.1097\/00005344-199212031-00001"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Wang, G.K., Russell, G. and Wang, S.Y. (2013): Persistent human cardiac Na<sup>+<\/sup> currents in stably transfected mammalian cells: Robust expression and distinct open-channel selectivity among Class 1 antiarrhythmics. Channels., <b>7<\/b>, 263-274.","DOI":"10.4161\/chan.25056"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Wang, Y., Mi, J., Lu, K., Lu, Y. and Wang, K. (2015): Comparison of gating properties and use-dependent block of Nav1.5 and Nav1.7 channels by anti-arrhythmics mexiletine and lidocaine. PLoS One., <b>10<\/b>, e0128653.","DOI":"10.1371\/journal.pone.0128653"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Ward, D.E., Camm, A.J. and Spurrell, R.A. (1979): Patterns of atrial activation during right ventricular pacing in patients with concealed left-sided Kent pathways. Br. Heart J., <b>42<\/b>, 192-200.","DOI":"10.1136\/hrt.42.2.192"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Yang, T. and Roden, D.M. (1996): Extracellular potassium modulation of drug block of I<sub>Kr<\/sub>. Implications for torsade de pointes and reverse use-dependence. Circulation, <b>93<\/b>, 407-411.","DOI":"10.1161\/01.CIR.93.3.407"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/42\/2\/42_183\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T12:47:40Z","timestamp":1498394860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/42\/2\/42_183\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.42.183","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}